Eyenovia Inc. (NASDAQ: EYEN)
$0.0855
-0.0001 ( -0.35% ) 3.2M
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
Market Data
Open
$0.0855
Previous close
$0.0856
Volume
3.2M
Market cap
$9.54M
Day range
$0.0833 - $0.0863
52 week range
$0.0770 - $2.5700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 21 | Sep 30, 2024 |
8-k | 8K-related | 13 | Sep 20, 2024 |
4 | Insider transactions | 1 | Sep 03, 2024 |
8-k | 8K-related | 16 | Sep 03, 2024 |
3 | Insider transactions | 1 | Sep 03, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 27, 2024 |
8-k | 8K-related | 52 | Aug 23, 2024 |
8-k | 8K-related | 22 | Aug 22, 2024 |
10-q | Quarterly Reports | 65 | Aug 14, 2024 |